"Designing Growth Strategies is in our DNA"

Varicella Virus Vaccine Market Size, Share & Industry Analysis, By Vaccine Type (Monovalent Vaccine, Combination Vaccine), By Application (Chickenpox, Herpes Zoster, Mumps/Measles/Rubella/Varicella (MMRV)), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, Others) And Regional Forecast 2021-2028

Region : Global | Report ID: FBI104688 | Status : Ongoing

 

KEY MARKET INSIGHTS

According to the Centers for Disease Control and Prevention (CDC), varicella affects nearly every child who have weakened immunity worldwide. Annual incidence rate is approximately 80-90 million cases. Lately, due to surge in the immunization programs, the disease burden is likely to reduce in the coming years. Rise in the procurement volume of the vaccine by government suppliers have led to product demand leading to increase in the sales of the company. As, the varicella virus is highly contagious, immunization of the new-borns is highly recommended by World Health Organization (WHO). Therefore, owing to continuous demand maintaining the supply balance is the key priority of the manufacturers.


The major factor driving the global varicella virus vaccine market is the increase in the adoption of varicella virus vaccines owing to surge in the hospitalization rate due to related diseases. Additionally, strong government immunization strategies and support for R&D is another factor driving the growth of the market.


On the flip side, higher cost associated with the development of vaccine is likely to cause a hindrance in the growth of the market.


Key Market Driver -

Surge in the Adoption of Varicella Virus Vaccines to Drive Product Sales

Key Market Restraint -

High R&D Investments Pertaining to Development of Vaccine to Restrict Growth


Market Segmentation:


By vaccine type, the global varicella virus vaccine market is segmented into monovalent vaccine and combination vaccine. Based on application, the market is classified as chickenpox, herpes zoster, and measles/mumps/rubella/varicella (MMRV). Based on distribution channel, the market is classified as hospital & retail pharmacies, government suppliers, and others.


From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.


Key Players Covered:


The major companies in the global varicella virus vaccines market report includes GlaxoSmithKline Plc, Merck & Co. Inc, Sanofi, Mitsubishi Tanabe Pharma Corporation, Novo Medi Sciences Pvt Ltd, Takeda Pharmaceutical Company Limited, GC Pharma, Bio-Med Pvt Ltd, and others.


Key Insights



  • New Product Launch

  • Snapshot of Pipeline Analysis

  • Prevalence of Key Diseases - For Key Regions/Countries

  • COVID-19 Impact on the Global Varicella Virus Vaccines Market

  • Key Industry Developments – Mergers, Acquisitions, and Partnerships


Regional Analysis:


The global varicella virus vaccines market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the global market in 2019, owing to presence of major players involved in development and commercialization of the vaccines. Europe held the second position in the global market owing to rise in the R&D investments for development of vaccine coupled with rise in number of immunization programmes. Awareness among the population about vaccination is the major factor leading to increased sales and demand for varicella vaccines in the Asia Pacific countries. This along with growing mergers and acquisitions between industry players is likely to promote the sales of the products in countries like China, India, and other countries. However, Latin America and Middle East & Africa are likely to witness significant growth during the forecast duration owing lesser adoption of the vaccines.


To gain extensive insights into the market, Request for Customization


Segmentation


























 ATTRIBUTE


  DETAILS

By Vaccine Type




  • Monovalent Vaccine

  • Combination Vaccine



By Application




  • Chickenpox

  • Herpes Zoster

  • Mumps/Measles/Rubella/Varicella (MMRV)



By Distribution Channel




  • Hospital & Retail Pharmacies

  • Government Suppliers

  • Others



By Geography




  • North America (USA, Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico, Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Varicella Virus Vaccine Industry Developments



  • In August 2020, during the pandemic GSK announced the launch of DTC campaign for Shingrix vaccine targeted against geriatric population for vaccination against varicella –zoster virus.

  • In December 2019, Sinovac Biotech Ltd announced the approval from China National Medical Products Administration (NMPA) for its varicella vaccine indicated against varicella-zoster virus for children aged 1 to 12 years old.


Varicella Virus Vaccine Market Size, Share and Global Industry Trend Forecast till 2026
  • Ongoing
  • 2020
  • 2017-2019

    CHOOSE LICENSE TYPE

  • $4850
    $6850
    $8850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Amgen
Galemed
Ansell
3M
Roche

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X